Skip to content
The National Council logo

Archive: Drug Pricing

Capitol Connector
Your source for the latest updates from Capitol Hill. We translate policy into practice so you can learn how policy trends will affect your work and how best to prepare.

Finalized Rule from CMS Preserves Medicare’s Six Protected Classes

Image related to this article

Shelley Starkey

Policy & Advocacy Coordinator

The Centers for Medicare and Medicaid Services (CMS) released a final rule on Thursday aimed at addressing rising drug prices and out-of-pocket expenses under Medicare Part D and Medicare Advantage. Notably, the final rule did not include previously-proposed measures that would have provided exceptions to Medicare’s “six protected classes,” a policy that ensures beneficiaries with complex health conditions, including mental illness, have access to a full range of medication treatment options. The announcement comes after six months of opposition to the proposals from Members of Congress and patient and provider advocates, including the National Council for Behavioral Health.

Read More |  View Comments

Share on LinkedIn

Trump Announces Blueprint to Lower Drug Prices

Image related to this article

Stephanie Pasternak

, National Council for Behavioral Health

Last Friday, President Trump announced the Administration’s plan to lower drug prices in a speech entitled ‘American Patients First,’ which highlights steps the Administration has taken, outlines future actions, and requests public comment on “even bolder actions” to bring down drug prices. The wide-ranging proposals include reforms to Medicare Part D and Part B, Medicaid, the Food and Drug Administration (FDA), the 340B Drug Discount program, and more.

Read More |  View Comments

Share on LinkedIn
©2019 National Council for Behavioral Health. All Rights Reserved.
The National Council for Behavioral Health is a 501(c)(3) nonprofit association (EIN 23-7092671).